We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Patient-Related Factors Predicting Stent Thrombosis in Percutaneous Coronary Interventions.
- Authors
Anghel, Larisa; Tudurachi, Bogdan-Sorin; Tudurachi, Andreea; Zăvoi, Alexandra; Clement, Alexandra; Roungos, Alexandros; Benchea, Laura-Cătălina; Zota, Ioana Mădălina; Prisacariu, Cristina; Sascău, Radu Andy; Stătescu, Cristian
- Abstract
Over the past four decades, percutaneous coronary intervention (PCI) safety and efficacy have significantly improved, particularly with the advent of the drug-eluting stent (DES). First-generation DESs reduced in-stent restenosis rates and targeted lesion revascularization; however, safety issues emerged, due to high incidences of stent thrombosis (ST) linked to death, myocardial infarction, and repeat revascularization. Second-generation DESs were developed to overcome these issues, reducing late-thrombotic-event risk while maintaining anti-restenosis efficacy. Nevertheless, ST still occurs with second-generation DES use. Stent thrombosis etiology is multifaceted, encompassing lesion-, patient-, procedural-, and stent-related factors. Overall, most early-stent-thrombosis cases are linked to procedural and patient-related aspects. Factors like premature discontinuation of dual antiplatelet therapy, resistance to clopidogrel, smoking, diabetes mellitus, malignancy, reduced ejection fraction or undertaking coronary angioplasty for an acute coronary syndrome can increase the risk of stent thrombosis. The aim of this study is to assess patient-related factors that potentially heighten the risk of stent thrombosis, with the objective of pinpointing and addressing modifiable contributors to this risk. By focusing on both patient- and procedure-related factors, a multifaceted approach to coronary revascularization can help minimize complications and maximize long-term benefits in managing ST.
- Subjects
PERCUTANEOUS coronary intervention; MYOCARDIAL infarction; CORONARY thrombosis; ACUTE coronary syndrome; PLATELET aggregation inhibitors
- Publication
Journal of Clinical Medicine, 2023, Vol 12, Issue 23, p7367
- ISSN
2077-0383
- Publication type
Article
- DOI
10.3390/jcm12237367